stockrowPulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) Shares outstanding
Pulse Biosciences, Inc's shares outstanding at the end of fiscal 2025 was $67.4M, up 15.4% from $58.4M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $71.9M. Over the past ten years it has ranged from $7.6M (fiscal 2015) to $67.4M (fiscal 2025) — the current reading is the highest in ten years. Pulse Biosciences, Inc ranks 19th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $67.4M | 15.41% |
| FY2024 | $58.4M | 17.41% |
| FY2023 | $49.7M | 46.57% |
| FY2022 | $33.9M | 21.35% |
| FY2021 | $28.0M | 20.29% |
| FY2020 | $23.2M | 12.06% |
| FY2019 | $20.7M | 21.48% |
| FY2018 | $17.1M | 15.75% |
| FY2017 | $14.8M | 34.02% |
| FY2016 | $11.0M | 45.53% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $71.9M | 3.94% |
| Jun 2026 | $69.2M | 1.77% |
| Mar 2026 | $68.0M | 0.89% |
| Dec 2025 | $67.4M | 0.01% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MMED MiniMed Group, Inc. compare | $281.0M |
| STVN Stevanato Group S.p.A. compare | $273.1M |
| NVST Envista Holdings Corporation compare | $163.4M |
| WRBY Warby Parker Inc. compare | $126.1M |
| PLSE Pulse Biosciences, Inc | $71.9M |
| MMSI Merit Medical Systems, Inc. compare | $60.4M |
| ATRC AtriCure, Inc. compare | $49.8M |
| TFX Teleflex Incorporated compare | $43.7M |
| ICUI ICU Medical, Inc. compare | $25.1M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Altman Z-score
- The full statement